Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer: A pilot study

Annals of Surgery

Volumn 264, Issue 6, 2016, Pages 1110-1115

  Liberale, Gabriel ^a   Vankerckhove, Sophie ^a   Gomez Caldon, Maria ^a   Ahmed, Bissan ^a   Moreau, Michel ^a   El Nakadi, Issam ^a   Larsimont, Denis ^a   Donckier, Vincent ^a   Bourgeois, Pierre ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Colorectal cancer; Detection; Fluorescence imaging; Indocyanine green; Intraoperative; Intravenous; Peritoneal carcinomatosis; Peritoneal metastases

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; EX VIVO STUDY; FALSE NEGATIVE RESULT; FEMALE; FLUORESCENCE IMAGING; HUMAN; INTRAOPERATIVE PERIOD; MALE; METASTASIS; PERITONEAL DISEASE; PILOT STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; INJECTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEAL NEOPLASMS; PROCEDURES; SECONDARY; THERMOTHERAPY;

ADULT; AGED; COLORECTAL NEOPLASMS; COLORING AGENTS; COMBINED MODALITY THERAPY; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; INJECTIONS; MALE; MIDDLE AGED; OPTICAL IMAGING; PERITONEAL NEOPLASMS; PILOT PROJECTS;

EID: 84953228572     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001618     Document Type: Article

References (25)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014, Available from http://globocan.iarc.fr Accessed January 16, 2015.
2. Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364-367.
3. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743.
4. Goere D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065-1071.
5. Elias D, Faron M, Iuga BS, et al. Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers. Ann Surg. 2015;261:157-163.
6. Blackham AU, Russell GB, Stewart JH 4th, et al. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21: 2667-2674.
7. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a Multicentric French Study. J Clin Oncol. 2009;28:63-68.
8. Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging. 2008;33:87-89.
9. Polom K, Murawa D, Rho Y, et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer. 2011;117:4817-4822.
10. Schaafsma BE, Mieog JSD, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323-332.
11. Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115: 2491-2504.
12. Satou S, Ishizawa T, Masuda K, et al. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma. J Gastroenterol. 2013;48:1136-1143.
13. Vahrmeijer AL, Hutteman M, van der Vorst JR, et al. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10: 507-518.
14. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res. 2007;134: 247-264.
15. Elias D, Liberale G, Manganas D, et al. Surgical treatment of peritoneal carcinomatosis. Ann Chir. 2004;129:530-533.
16. van Dam GM, Themelis G, Crane LMA, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor: targeting: first inhuman results. Nature Med. ;17:1315-1320.
17. Horowitz NS. Laparoscopy in the near infrared with ICG detects microscopic tumor in women with ovarian cancer: 0078. Int J Gynecol Cancer. 2006; 16:616-623.
18. Tummers QRJC, Hoogstins CES, Peters AAW, et al. The value of intraoperative near-infrared fluorescence imaging based on enhanced permeability and retention of indocyanine green: feasibility and false-positives in ovarian cancer. PLoS ONE. 2015;10:e01297766.
19. van der Vorst JR, Schaafsma BE, Hutteman M, et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119: 341-348.
20. Alacam B, Yazici B, Intes X, et al. Extended kalman filtering for the modeling and analysis of ICG pharmacokinetics in cancerous tumors using NIR optical methods. IEEE Trans Biomed Eng. 2006;53:1861-1871.
21. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophtalmol. 2000;45:15-27.
22. Maeda H,Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics. J Control Release. 2000;65:271-284.
23. Goere D, Souadka A, Faron M, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22: 2958-2964.
24. Berger KL, Nicholson SA, Dehdashti F, et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol. 2000;174:1005-1008.
25. O'Connor OJ, McDermott S, Slattery J, et al. The use of PET-CT in the assessment of patients with colorectal carcinoma. Int J Surg Oncol. 2011; doi:10.1155/2011/846512.